Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent.
D000243:Adenosine Deaminase / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000378:metabolism; D003500:Cyclization; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D009700:Nucleoside Deaminases / Q000378:metabolism*; D018139:Simplexvirus / Q000187:drug effects; D014616:Vaccinia virus / Q000187:drug effects; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology
D000970:Antineoplastic Agents; D000998:Antiviral Agents; C014387:carbocyclic arabinosyladenine; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D014740:Vidarabine